Drug intelligence / Profile preview

188Re-microspheres

Development stage
Phase 1
Lead developer
Post Graduate Institute of Medical Education and Research
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intra-arterial, Intraarticular
01

Overview

188Re-microspheres (rhenium-188 microspheres) is an indigenously developed, cost-effective therapeutic radiopharmaceutical designed for selective internal radiation therapy (SIRT) of unresectable liver cancers, such as hepatocellular carcinoma (HCC). It consists of microspheres labeled with rhenium-188 (188Re), a theranostic radionuclide that emits high-energy beta particles for localized tumor destruction and low-energy gamma photons suitable for SPECT/CT imaging and post-therapy dosimetry. Administered via intra-arterial infusion into the hepatic artery, the microspheres lodge in the microvasculature of the tumor, delivering targeted radiation while sparing healthy liver tissue. The development of this agent, particularly as a freeze-dried cold kit, offers a sustainable and affordable alternative to expensive commercial yttrium-90 (90Y) microspheres in resource-limited settings.

Other names
188Re microspheres188Re-labeled microspheresRe-188 microspheresRe188 microspheresRe 188 microspheresrhenium-188 microspheresrhenium188 microspheresrhenium 188 microspheresrhenium-188-labeled microspheresrhenium188-labeled microspheresrhenium 188-labeled microspheres

Beyond the preview

Go deeper on 188Re-microspheres.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 188Re-microspheres.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call